Recurrent hyperkalaemia management and use of renin–angiotensin–aldosterone system inhibitors: a European multi-national targeted chart review
Autor: | Thierry Schulmann, Luis M. Ruilope, Lars H. Lund, Patrick Rossignol, Markus Ketteler, Georgiana Cornea, Marc Pignot, David C. Wheeler, Adamasco Cupisti |
---|---|
Přispěvatelé: | Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Hospital Universitario 12 de Octubre [Madrid], University of Pisa - Università di Pisa, Department of General Internal Medicine and Nephrology, Robert-Bosch-Krankenhaus, University of Split School of Medicine, Queen Mary University of London (QMUL), Kantar Health GmbH, Real World Research & Value, Vifor Pharma Group, Karolinska Institute, Karolinska University Hospital [Stockholm], This study was developed and funded by the Vifor Pharma, Switzerland., BOZEC, Erwan |
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Transplantation
medicine.medical_specialty business.industry MEDLINE 030204 cardiovascular system & hematology 3. Good health [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system 03 medical and health sciences 0302 clinical medicine Multi national [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system Nephrology Chart review HEART FAILURE KIDNEY DISEASE POTASSIUM MORTALITY Renin–angiotensin system Medicine 030212 general & internal medicine business Intensive care medicine Letters to the Editor AcademicSubjects/MED00340 ComputingMilieux_MISCELLANEOUS |
Zdroj: | Clinical Kidney Journal Clinical Kidney Journal, Oxford University Press, 2020, 13 (4), pp.714-719. ⟨10.1093/ckj/sfz129⟩ Clinical Kidney Journal, 2020, 13 (4), pp.714-719. ⟨10.1093/ckj/sfz129⟩ |
ISSN: | 2048-8505 2048-8513 |
DOI: | 10.1093/ckj/sfz129⟩ |
Popis: | Hyperkalaemia often occurs due to impaired excretion of potassium in patients with chronic kidney disease and other chronic conditions such as heart failure and/or diabetes mellitus. |
Databáze: | OpenAIRE |
Externí odkaz: |